Liver metastasis is the major cause of death among colorectal cancer patients. Many gene products have been associated with
the colon cancer cells' ability to metastasize to the liver, including carcinoembryonic antigen (CEA) and mucins. In this
study we examined changes in expression of 384 genes in a model of human colorectal cancer metastasis in nude mice. Using
DNA microarrays, we compared expression between MIP-101 cells, a poorly metastatic human colon cancer cell line, with an interferon-beta
(IFN-β) resistant subline of MIP-101 (β-MIP) that is metastatic to the liver. Treatment of β-MIP cells with increasing concentrations
of IFN-β caused a reversion to the non-metastatic phenotype. The array data showed down-regulation of genes involved in apoptosis
in β-MIP cells and their return to the MIP-101 pattern upon IFN-β treatment. Cluster analysis also showed involvement of genes
belonging to cell cycle, angiogenesis and invasion pathways. Selected genes were chosen to validate the microarray data by
semi-quantitative RT-PCR. Association between gene expression pattern and metastatic phenotype was verified by intra-splenic
injection in nude mice. The number of genes examined in this study was small, but carefully selected. Significant changes
associated with cell growth and survival were observed, which gave the metastatic cells an advantage to grow in the liver.
This information may help identifying new markers for colorectal cancer prognosis as well as aid the development of new therapeutic
approaches.
colorectal cancer - expression profiling - interferon-beta - liver - metastasis
This revised version was published online in July 2006 with corrections to the Cover Date.